Aquestive Therapeutics, Inc.
—- Market cap
- $670.23M
- Debt
- +$45.00M
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 94% equity / 6% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AQST stock price at premium vs VAC $5.34 current versus $0.26 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VAC's multiple
Implied fair value · at AQST's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AQST FY 2025 (ended Dec 31, 2025) · VAC FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 94% equity / 6% debt
Capital structure 51% equity / 49% debt · EV / Revenue 1.35x · EV / EBITDA 1359.05x
VAC carries the larger enterprise value at $6.80B against $715.23M; VAC trades on the lower EV / Revenue multiple (1.35x vs 16.06x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Aquestive Therapeutics, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Marriott Vacations Worldwide Corp · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-1.34x
1.77x
Net debt / EBITDA
Leverage against operating earnings
—
625.60x
Cash and equivalents
Liquid reserves on the balance sheet
—
$406.00M
Total debt
Interest-bearing obligations outstanding
$45.00M
$3.53B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.